Profile
James J.
Antal served as Senior Vice President-Finance at Northrop Grumman Space & Mission Systems Corp.
from 1978 to 1996.
He then worked as Chief Investment Officer at Experian Plc from 1996 to 2002.
Antal also served as Independent Director at SIGA Technologies, Inc. from 2004 to 2022, Independent Director at Cleveland BioLabs, Inc. from 2006 to 2016, and Chief Financial Officer at Pathway Data, Inc. from 2005 to 2009.
He was also a Director at CoreLogic Solutions LLC and Senior Vice President-Finance at TRW Information Systems Group.
Antal received his undergraduate degree from The Ohio State University in 1973.
Former positions of James Antal
| Companies | Position | End |
|---|---|---|
| SIGA TECHNOLOGIES, INC. | Director/Board Member | 2022-07-30 |
| STATERA BIOPHARMA, INC. | Director/Board Member | 2016-07-07 |
| GENELINK, INC. | Director/Board Member | 2009-08-16 |
| Pathway Data, Inc. | Director of Finance/CFO | 2008-12-31 |
| EXPERIAN PLC | Chief Investment Officer | 2001-12-31 |
Training of James Antal
| The Ohio State University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| GENELINK, INC. | Health Services |
| EXPERIAN PLC | Commercial Services |
| SIGA TECHNOLOGIES, INC. | Health Technology |
| Private companies | 5 |
|---|---|
| Pathway Data, Inc. | |
| Northrop Grumman Space & Mission Systems Corp. | Producer Manufacturing |
CoreLogic Solutions LLC
 CoreLogic Solutions LLC Data Processing ServicesTechnology Services CoreLogic Solutions LLC provides real estate services. It offers asset management, property inspection and property preservation, property appraisal or valuation, and tax information services. The company was founded on November 12, 1997 and is headquartered in Irvine, CA. | Technology Services |
| TRW Information Systems Group | |
Cleveland BioLabs, Inc.
 Cleveland BioLabs, Inc. Pharmaceuticals: MajorHealth Technology Cleveland BioLabs, Inc. operates as a biopharmaceutical company, which engages in the research and development of drugs. It focuses on oncology and acute radiation syndrome. It offers Entolimod, Mobilan, CBL0137, and SA-702. The company was founded by Andrei V. Gudkov and Yakov Kogan on June 5, 2003 and is headquartered in Buffalo, NY. | Health Technology |
- Stock Market
- Insiders
- James Antal
